Press Releases


Filter: All | Regulatory | Non regulatory

2023

2023-11-24

Report from the extraordinary general meeting in Scandinavian Real Heart AB on November 24, 2023

2023-11-16

Interim Report 230701-230930

2023-11-13

Realheart provides an update on the development and commercialization of its artificial heart

2023-11-08

Notice to Attend the Extraordinary General Meeting in Scandinavian Real Heart AB

2023-11-01

Realheart has successfully established a novel test system to evaluate hemolysis of its total artificial heart

2023-10-30

Giovanni Lauricella is adjuncted to Realheart’s board of directors

2023-09-01

Realheart selected for Business Sweden’s Catalyst programme

2023-08-30

Stuart McConchie Appointed Adjunct Board Member to Realheart

2023-08-24

Interim Report 230401-230630

2023-08-23

Realheart’s CEO to Speak at China Heart Congress

2023-08-22

Realheart to Present at Three Scientific Conferences in Europe

2023-08-10

Magnus Öhman Appointed Adjunct Board Member to Realheart

2023-08-02

Realheart Announces Last day of Trading With BTU and First day of Trading With Warrants of Series TO2

2023-07-26

Realheart Performs a Directed Issue to EIC in Connection With the Completed Rights Issue

2023-07-26

Realheart Performs a Directed Issue of Units to Underwriters in Connection With the Completed Rights Issue

2023-07-12

Scandinavian Real Heart AB announces outcome in the Company’s rights issue

2023-07-07

The Subscription Period in Realheart’s Rights Issue Ends Today

2023-07-05

Realheart Awarded Close to SEK 1 Million From Tillväxtverket and Region Västmanland

2023-07-04

The Subscription Period in Realheart’s Rights Issue Ends on Friday

2023-07-03

German Cardiac Surgeon Estimates That the Market for a Company That can Provide a Good Enough Artificial Heart is Huge

2023-07-03

Realheart Enters Into Collaboration With Sahlgrenska for Clinical Studies

2023-06-28

Realheart Gets Go-Ahead for International Trademark Protection

2023-06-21

Realheart's Chief Medical Officer Dr. Ulf Kjellman in an Interview with Trading Direkt Healthcare, on the Topic of Artificial Hearts

2023-06-20

The Subscription Period in Realheart’s Rights Issue Starts Today

2023-06-19

Correction: Realheart Publishes Prospectus in Connection With Rights Issue of Units of Approximately SEK 56 Million

2023-06-19

Realheart Publishes Prospectus in Connection With Rights Issue of Units of Approximately SEK 56 Million

2023-06-15

Correction: Bulletin From the Annual General Meeting in Scandinavian Real Heart AB on 14 June 2023

2023-06-15

Cardiac Surgeon Dilek Gürsoy Speaks About Realheart's Artificial Heart at Impact LECH

2023-06-14

Bulletin From the Annual General Meeting in Scandinavian Real Heart AB on 14 June 2023

2023-06-08

Realheart Part of Vinnova Project for Cordless TAH Technology

2023-06-07

Board Member in Realheart Resigns at his own Request

2023-05-24

Realheart Releases the Annual Report for 2022

2023-05-16

Notice to Attend the Annual General Meeting in Scandinavian Real Heart AB

2023-05-15

EIC Fund to Invest in Scandinavian Real Heart AB

2023-05-15

Realheart Carries out new Issues of Shares of Maximum SEK 73 Million

2023-05-12

Realheart Returns to Communicating in Both Swedish and English

2023-05-11

Interim Report 230101-230331

2023-05-09

Realheart to Proceed With Communication in English Only

2023-05-03

Scientists at Scandinavian Real Heart and at the University of Bath Publish the World’s First Computer Simulation Method for Dual Mechanical Heart Valves in Series

2023-04-27

Results of Scandinavian Realheart’s Total Artificial Heart Demonstrating Lower Rates of Hemolysis, Published in the Journal Artificial Organs

2023-04-19

Realheart Moves the Date of the Annual General Meeting and Publication of the Annual Report for 2022

2023-04-18

Joseph Bornoff’s Simulations of the Realheart Published in Scientific Reports

2023-04-12

Market Need in the US and Europe is Estimated at 200,000 Artificial Hearts per Year - Equivalent to SEK 200 Billion - And the Trend is Accelerating

2023-03-29

Realheart's CEO to Present at the Swiss Nordic Bio Zürich Healthcare Investor Conference

2023-03-27

Cardiac Surgeon Ulf Kjellman Takes Over as Chief Medical Officer(CMO) at Realheart

2023-03-03

Use of Warrants of Series TO1 in Scandinavian Real Heart AB

2023-03-02

Realhearts Azad Najar Keynote Speaker at Dubai Innovation Conference

2023-02-24

Year-end Report 22-01-01 until 22-12-31

2023-02-22

REMINDER: HEART TO1 Redemption Period Coming to an end

2023-02-21

Professor Bart Meyns Strengthens Realheart's Advisory Board

2023-02-09

Dr Azad Najar Keynote Speaker at the Opening of the AI Congress in Cairo

2023-01-31

Correction: the Subscription Price for Realhearts Warrant TO1 is SEK 2.36

2023-01-30

Information on Trading and Exercise of Warrants of Series TO1 in Realheart

2023-01-23

Dr. Ulf Kjellman Strengthens Realheart's Medical Advisory Board

2023-01-19

Realheart and KTH Optimize Artificial Heart Function in Sweden's First Patient Simulator

2023-01-10

Realheart Reaches New Milestone With the World’s First Four Chamber Artificial Heart

2022

2022-12-07

Correction: Interim Report 220701-220930

2022-11-18

Interim Report 220701-220930

2022-10-27

Third Animal Implantation Completed - Trials Continue

2022-10-25

Realheart Featured in German TV Documentary

2022-10-10

Realheart Has Been Granted an Additional Loan From Almi

2022-10-03

Realheart's CEO to Speak at the Fokus Patient Forum on October 5

2022-09-26

Third Implantation in Sheep Scheduled to Take Place in October

2022-09-06

Realheart Team Attends ESAO Conference in Austria

2022-08-29

Realheart's Faisal Zaman to Present at Blood Injury Conference

2022-08-19

Interim Report 220101-220630

2022-07-08

Realheart Successfully Completes Second Animal Implant of its Total Artificial Heart

2022-06-27

Jonas Caspari Bark New CFO at Realheart

2022-06-23

Second Animal Implantation To Take Place July 6

2022-06-15

Realheart to Host International Conference in Västerås 15 June

2022-06-14

Realheart's CEO in Filmed Company Presentation: "the biggest news for 2022 is that the clinical version of Realheart® TAH is fully developed and under production"

2022-06-02

First Animal Trial with Clinical Version Completed

2022-05-30

Realhearts CEO Elected to the ISMCS Board of Trustees

2022-05-27

Realheart’s CEO Presents Blood Results at the ISMCS Conference in Hannover

2022-05-26

Realheart and KTH Receive SEK 4 Million Grant from Vinnova

2022-05-19

Implantation with clinical version rescheduled for change of animal

2022-05-13

Realheart Releases the Annual Report for 2021 in English

2022-05-09

Realheart is recruiting Lead Systems Engineer

2022-05-02

Realheart has been granted two more US patents

2022-05-01

Realheart releases the annual report for 2021

2022-04-28

Improved controller for clinical trials results in six-month delay

2022-04-26

Realheart to recruit new CFO

2022-04-13

Realheart set to begin animal studies with clinical version

2022-04-07

Realheart initiates collaboration with researchers at KTH

2022-03-31

Clinical version of Realheart TAH being tested on virtual patients

2022-03-23

Realheart to establish Australian subsidiary

2022-03-17

Realheart recruits clinical strategist and electronics expert

2022-03-14

Realheart hires investment advisor in the UAE

2022-03-09

Artificial Organs publishes Libera Fresiello's research

2022-02-24

Christer Norström appointed acting chairman of Realheart

2022-02-23

Realheart and Berlin Heart receive joint 10 MSEK grant for membrane production

2022-02-21

Realheart Chairman Göran Hellers has died

2022-02-08

Update on Realheart's animal studies

2022-01-18

Realheart provides clarification on UAE media reports

2022-01-18

Azad Najar a speaker at the ICPM conference today

2021

2021-12-21

Realheart receives SEK 200,000 funding from Vinnova

2021-12-16

Realheart receives an EU grant of 2.5 million euros for its artificial heart

2021-12-15

Realheart's artificial heart becomes 10-20 percent smaller

2021-12-09

Realheart receives new US patent for its pump concept

2021-11-11

Realheart to continue animal studies using clinical version of its artificial heart

2021-11-04

Realheart collaborates with Hydrix for artificial heart clinical controller

2021-10-27

Realhearts CEO invited to speak at EUMS-ISMCS conference

2021-09-27

Realheart has recruited a biomedical engineer to its blood lab

2021-09-21

Joseph Bornoff’s computer simulation presentation now available

2021-09-13

Dr Katharine Fraser’s Realheart study published in Artificial Organs

2021-09-07

Realheart’s CEO speaking at the ESAO Congress on September 10

2021-09-06

Realheart´s new animal studies are about to start

2021-09-03

Realheart enters partnership with software experts Codialist

2021-09-02

Realheart brings together expertise from five other artificial heart projects

2021-08-31

Realheart prepares listing on Nasdaq First North Growth Market break

2021-08-17

Realheart pilots implantation on virtual patients

2021-07-05

Dr Fresiello’s ASAIO presentation now available on Youtube

2021-06-24

Summer break in Realheart´s animal studies

2021-06-16

Realheart recruits CTO from German artificial heart start-up

2021-06-14

Realheart strengthens R&D Team with three engineers

2021-06-01

Why so few are treated with artificial hearts – expert explains

2021-05-28

Realheart granted SEK 500,000 for blood research

2021-05-24

Realheart receives approval to participate in the second application stage of Horizon Europe for soft funding

2021-05-04

Realheart to present international research at two conferences this summer

2021-04-13

Realheart enters Supplier Agreement for Critical Parts

2021-04-06

Azad Najar a speaker at the ICPM conference April 7-9

2021-03-22

Realheart initiates chronic animal trials today

2021-03-19

Realheart's development plan 2021

2021-03-08

Correction of press release: Dr Ina Laura Perkins new CEO of Realheart

2021-03-08

Dr Ina Laura Perkins new CEO of Realheart

2021-01-27

Realheart's CEO in Al Jazeera interview: "We will solve the problem of the donated organ shortage"

2020

2020-12-10

Realheart's CEO invited to speak at EUMS

2020-12-07

Realheart receives new Vinnova financing to increase international competitiveness

2020-10-29

Advanced sensors make Realheart's heart smarter

2020-10-26

Realheart and Linköping University together in the forefront of blood flow analysis

2020-10-09

Realheart resumes animal studies

2020-10-01

Realheart launches scientific advisory board

2020-06-12

Realheart strengthens research group with new doctoral student in computer simulation

2020-06-11

Realheart signs an important agreement with largest European heart pump manufacturer

2020-05-05

Realheart establishes new partnerships

2020-03-19

New high-tech version of Realheart's artificial heart

2020-03-19

Realheart development plan 2020

2020-01-21

Realheart releases footage from the animal trial surgeries

2020-01-07

Results from Realheart's latest trial series: The sheep was awakened and able to eat

2019

2019-12-17

Realheart on display at the Technical Museum

2019-10-11

Realheart reports the fall’s development plan

2019-10-08

Realheart TAH is gentler to the blood according to comparative study

2019-09-30

Real Heart optains grant of 500 000 SEK

2019-09-25

New scientific article published

2019-07-12

Realheart summarizes the spring’s animal trials and tests automatic control

2019-06-04

Realheart strenghens its patent portfolio

2019-05-29

Realheart uses sheep as animal model and performs fitting trials